LTRN

Lantern Pharma Inc. (LTRN) Porter's 5 Forces Analysis (2026)

Invetso Score: 2.8/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Overall Score

Score: 2.8 (Weak)

Threat Of New Entrants

Score:

Very low barriers to entry given the company’s tiny market cap and lack of demonstrated scale advantages.

Weak balance sheet and negative profitability reduce the ability to invest in durable entry barriers.

Bargaining Power Of Suppliers

Score:

Limited evidence of supplier concentration, but the company’s small scale likely leaves it with little purchasing leverage.

Negative operating performance suggests it may have limited flexibility in negotiating favorable input terms.

Bargaining Power Of Buyers

Score:

No pricing power is evident, with zero reported margins and negative returns indicating customers can pressure economics.

The company’s small size likely limits its ability to resist buyer demands on price and terms.

Threat Of Substitutes

Score:

With no visible margin structure or profitability, the offering does not appear differentiated enough to command strong customer lock-in.

Low scale and weak economics make substitution risk difficult to offset.

Industry Rivalry

Score:

Persistent losses and zero margins imply intense competitive pressure and limited differentiation.

Small scale and weak cash generation leave little room to outspend rivals or defend share.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Lantern Pharma Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →